Ribovate Therapeutics

Ribovate is developing the next generation targeted mRNA-lipid nanoparticle therapeutic platform.

Startup Details

Co-Founded by: Drew Weissman and Hamideh Parhiz

Participates in PCI Ventures UPstart

PCI Hosts its 7th Annual Innovation@Penn Conference

Penn Startups Raising Money in 2023

PCI Ventures @ Pennovation Works Showcase Shines Spotlight on Penn-Affiliated Startups Making a Difference

Penn Spinout and I-Corps Participant Innervace Raises $40 Million for Parkinson’s Disease Research



Skip to content